HSIC

Leerink Partners Initiates Coverage of Henry Schein (HSIC) with Market Perform Recommendation

Fintel reports that on February 26, 2024, Leerink Partners initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Market Perform recommendation.

Analyst Price Forecast Suggests 3.74% Downside

As of February 23, 2024, the average one-year price target for Henry Schein is 76.87. The forecasts range from a low of 65.65 to a high of $86.10. The average price target represents a decrease of 3.74% from its latest reported closing price of 79.86.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Henry Schein is 13,584MM, an increase of 7.02%. The projected annual non-GAAP EPS is 5.53.

What is the Fund Sentiment?

There are 1204 funds or institutions reporting positions in Henry Schein. This is an increase of 17 owner(s) or 1.43% in the last quarter. Average portfolio weight of all funds dedicated to HSIC is 0.19%, a decrease of 8.57%. Total shares owned by institutions increased in the last three months by 3.22% to 141,271K shares. HSIC / Henry Schein, Inc. Put/Call Ratios The put/call ratio of HSIC is 2.20, indicating a bearish outlook.

What are Other Shareholders Doing?

HSIC / Henry Schein, Inc. Shares Held by Institutions

Generation Investment Management Llp holds 11,965K shares representing 9.21% ownership of the company. In it's prior filing, the firm reported owning 12,168K shares, representing a decrease of 1.69%. The firm decreased its portfolio allocation in HSIC by 13.62% over the last quarter.

Invesco holds 5,789K shares representing 4.45% ownership of the company. In it's prior filing, the firm reported owning 4,390K shares, representing an increase of 24.17%. The firm increased its portfolio allocation in HSIC by 18.81% over the last quarter.

American Century Companies holds 5,507K shares representing 4.24% ownership of the company. In it's prior filing, the firm reported owning 4,719K shares, representing an increase of 14.31%. The firm increased its portfolio allocation in HSIC by 4.64% over the last quarter.

Jpmorgan Chase holds 4,794K shares representing 3.69% ownership of the company. In it's prior filing, the firm reported owning 4,766K shares, representing an increase of 0.57%. The firm decreased its portfolio allocation in HSIC by 10.69% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 4,044K shares representing 3.11% ownership of the company. In it's prior filing, the firm reported owning 4,096K shares, representing a decrease of 1.29%. The firm decreased its portfolio allocation in HSIC by 6.18% over the last quarter.

Henry Schein Background Information
(This description is provided by the company.)

Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.